Application of protein fingerprinting technology in diagnosing 4 types of leukemia

doi:10.3969/j.issn.1673-8640.2015.02.017

Abstract

Abstract: Objective

To establish protein fingerprinting model for the diagnosis of leukemia through determining 4 typical types of leukemia.

Methods

A total of 16 acute myeloblastic leukemia M2a samples, 18 chronic myelocytic leukemia samples, 14 acute lymphoblastic leukemia samples and 16 acute myeloblastic leukemia M3 samples were determined by protein fingerprinting technology. The comparison of biomarkers was performed by Biomarker Wizard and Biomarker Patterns 5.0 to establish a diagnosis tree model.

Results

The diagnosis tree model combined with 3 biomarkers ( m/z: 3 376, 8 055 and 9 421) could detect 75% acute myeloblastic leukemia M2a (12/16),100.0% chronic myelocytic leukemia (18/18), 71.4% acute lymphoblastic leukemia (10/14) and 87.5% acute myeloblastic leukemia M3 (12/14).

Conclusions

The protein fingerprinting model established by 3 protein features maybe a novel method for diagnosing 4 types of leukemia.

Key words: Leukemia, Typing, Protein fingerprinting technology

CLC Number:

R446.11

HUANG Hua, CHEN Linxing, LIN Meice, HUANG Jingyu.. Application of protein fingerprinting technology in diagnosing 4 types of leukemia[J]. Laboratory Medicine, 2015, 30(2): 173-176.

Figures/Tables 3

References 13

[1]	霍菲菲,刘欣,孙自敏,等.397例急性白血病细胞遗传学与FAB分型相关性研究[J].中国实验血液学杂志,2011,19(1):6-10.
[2]	姚尔固,林凤茹,郭晓楠,等.恶性血液病的诊断与治疗[M].北京:人民军医出版社,2004: 27-31.
[3]	张之南. 血液病诊断及疗效标准[M].2版.北京:科学技术出版社,1998:171-211.
[4]	刘建栋, 李永哲, 李宁, 等. 血液蛋白质组与质谱仪检测流程标准化初探[J]. 基础医学与临床,2007, 27(2): 193-197.
[5]	RODLAND KD.Proteomics and cancer diagnosis: the potential of mass spectrometry[J]. Clin Biochem,2004, 37(7): 579-583.
[6]	陈主初. 肿瘤蛋白质组学的研究进展[J].癌症,2004,23(2):113-117.
[7]	尚利华,于雁.蛋白质芯片SELDI-TOF-MS技术及其在肿瘤检测中的应用[J].实用肿瘤学杂志,2005,19(6):472-476.
[8]	PETRICOIN EF, ARDEKANI AM, HITT BA, et al.Use of proteomic patterns in serum to identify ovarian cancer[J]. Lancet, 2002, 359(9306): 572-577.
[9]	WANG L, SU D, YAN HJ, et al.Primary study of lymph node metastasis-related serum biomarkers in breast cancer[J]. Anat Rec(Hoboken), 2011, 294(11):1818-1824.
[10]	屠世良, 颜怀军, 郦卫星, 等. 癌胚抗原阴性的结直肠癌检测和结直肠癌预后相关生物标记[J].基础医学与临床,2007,27(8):926-931.
[11]	LIANG Y, FANG MR, LI JC, et al.Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry[J]. Exp Mol Pathol, 2006, 81(2):176-180.
[12]	SU Y, SHEN J, QIAN H, et al.Diagnosis of gastric cancer using decision tree classification of mass spectral data[J]. Cancer Sci, 2007, 98(1): 37-43.
[13]	ADAM BL, QU Y, DAVIS JW, et al.Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperlasia and healthy men[J]. Cancer Res, 2002, 62(13): 3609-3614.

分组	例数	准确率	0组 (16例)	1组 (18例)	2组 (14例)	3组 (16例)
0组	16	75.000	12	0	4	0
1组	18	100.000	0	18	0	0
2组	14	71.429	2	0	10	2
3组	16	87.500	2	0	0	14

分组	例数	准确率	0组 (16例)	1组 (18例)	2组 (14例)	3组 (16例)
0组	16	75.000	12	0	4	0
1组	18	100.000	0	18	0	0
2组	14	71.429	2	0	10	2
3组	16	87.500	2	0	0	14

[1]	GUO Yuanyuan, SONG Hui, ZHANG Lin. Correlation between serum Sema4D，fibrinogen-to-albumin ratio and prognosis in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2025, 40(8): 769-774.
[2]	WU Xiaoqiong, CHEN Dongmiao, LIANG Yumin, WANG Congrong. Influence of Helicobacter pylori Ⅰ and Ⅱ infection on chronic gastritis [J]. Laboratory Medicine, 2025, 40(8): 798-803.
[3]	YANG Shu, YANG Lihua, SHENG Fengsong, JIANG Yonggen, QIAO Xuefei, ZHU Tianyue, YU Zifan, TANG Yiming. Drug resistance genes，virulence genes and molecular typing characteristics of 101 isolates of Campylobacter based on whole genome sequencing [J]. Laboratory Medicine, 2025, 40(7): 673-679.
[4]	SUN Gang, SUN Hui, BAO Lina, LIU Xianwei, LU Mingyang, LIU Jing, TIAN Yuan. Drug resistance and molecular epidemiology of OS-MRSA in Hulunbuir，Inner Mongolia [J]. Laboratory Medicine, 2025, 40(6): 551-554.
[5]	SHI Fangjing, HU Shanshan, LUO Xinguo, ZHU Yan, YU Fangquan, YE Hongwei. Expression of programmed death-1/programmed death-ligand 1 in chronic lymphocytic leukemia patients and its correlation with T lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(6): 592-595.
[6]	MA Jingyun, WANG Mengmeng, XIONG Boyu, DAI Zhuowen, PAN Yueyue, WANG Qiong. Research progress in phenotypic characteristics and treatment efficacy evaluation of acute promyelocytic leukemia variants [J]. Laboratory Medicine, 2025, 40(6): 606-614.
[7]	LIU Min, SUN Hengjuan, DU Chengkan, XIA Min, JIANG Linlin, WENG Wenhao, ZHANG Hong. Laboratory analysis of 6 cases of acute megakaryocytic leukemia in children [J]. Laboratory Medicine, 2025, 40(5): 484-488.
[8]	TANG Jiemei, WANG Binbin, LIU Na, TANG Gusheng. Influence of concomitant gene mutation on acute myeloid leukemia patients with RUNX1::RUNX1T1 fusion [J]. Laboratory Medicine, 2025, 40(2): 186-191.
[9]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[10]	LUO Yuanmei, LIU Chang, CHEN Lilong, LI Zhenzhang, YUE Yubiao, LI Yang, XU Lingqing. Acute promyelocytic leukemia diagnosis assisted by YOLOV8 deep learning model [J]. Laboratory Medicine, 2025, 40(10): 998-1003.
[11]	LIU Mengna, WANG Hongling, BAI Ping, CAI Yu, LI Li. Research progress on laboratory diagnosis and treatment of ETP-ALL [J]. Laboratory Medicine, 2025, 40(1): 1-7.
[12]	WANG Hongling, CAI Yu, LIU Mengna, BAI Ping. Clinical characteristic analysis of ETP-ALL patients with POX positive rate>3% [J]. Laboratory Medicine, 2025, 40(1): 20-24.
[13]	DING Jing, ZHANG Chunling, WANG Xiaorui, LI Huidan, WANG Hongling, LIU Weiling, LIN Lihui, LI Li. Laboratory diagnosis and prognostic factor analysis of core binding factor-related acute myeloid leukemia [J]. Laboratory Medicine, 2024, 39(7): 673-681.
[14]	YAN Jianghong, WANG Le, MA Lin, YANG Shuo, GUO Weiwei, ZHAO Mengchuan, LIU Zehao, ZHAI Xiaoying. Clinical characteristics of acute lymphoblastic leukemia children infected with Epstein-Barr virus [J]. Laboratory Medicine, 2024, 39(6): 583-586.
[15]	WANG Xuqin, LIN Qianru, FENG Wanqing, DONG Yuan, YU Xiaolei, LIU Changhe, NING Zhen, SHEN Xin, PAN Qichao, LIN Yi. Validation of HIV-1 integrase genotyping sequence assay [J]. Laboratory Medicine, 2024, 39(4): 369-375.